BAXTER INTERNATIONAL INC
BAXTER INTERNATIONAL INC
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 2,150 | 2,017 | 1,966 | 1,726 | 1,686 | 2,294 | 1,764 | 1,420 | 1,574 | 2,826 | 3,078 | 5,716 | |||||
Accounts Receivable Net Current | 1,856 | 1,698 | 1,861 | 1,777 | 1,773 | 1,646 | 1,679 | 1,729 | 2,639 | 2,521 | 1,719 | 2,512 | |||||
Inventory Net | 2,259 | 2,316 | 2,232 | 2,460 | 2,384 | 2,170 | 2,046 | 2,103 | 2,985 | 2,988 | 1,918 | 2,873 | |||||
Prepaid Expense And Other Assets Current | 724 | 816 | 813 | 970 | 906 | 925 | 753 | 720 | 874 | 865 | 706 | 861 | |||||
Assets Of Disposal Group Including Discontinued Op… | - | - | 0 | 0 | 0 | 0 | 2,611 | 2,892 | - | - | 2,179 | 0 | |||||
Assets Current | 6,989 | 6,847 | 6,872 | 6,933 | 6,749 | 7,035 | 8,853 | 8,864 | 8,593 | 9,400 | 9,600 | 12,034 | |||||
Property Plant And Equipment Net | 2,913 | 2,913 | 2,910 | 2,812 | 2,802 | 2,717 | 2,870 | 2,833 | 4,314 | 4,370 | 2,871 | 4,278 | |||||
Goodwill | 4,886 | 4,899 | 4,929 | 5,400 | 5,395 | 5,338 | 5,275 | 5,783 | 6,001 | 6,430 | 5,793 | 6,407 | |||||
Intangible Assets Net Excluding Goodwill | 4,073 | 4,218 | 4,369 | 4,805 | 4,950 | 5,081 | 5,223 | 5,449 | 5,741 | 5,905 | 5,918 | 6,230 | |||||
Operating Lease Right Of Use Asset | 261 | 277 | 276 | 270 | 289 | 301 | 306 | 327 | 524 | 531 | 336 | 519 | |||||
Other Assets Noncurrent | 669 | 692 | 699 | 847 | 861 | 832 | 755 | 886 | 1,139 | 1,152 | 809 | 1,188 | |||||
Disposal Group Including Discontinued Operation As… | - | - | 0 | 0 | 0 | 0 | 2,500 | 2,534 | - | - | 2,949 | 0 | |||||
Assets | 19,791 | 19,846 | 20,055 | 21,067 | 21,046 | 21,304 | 25,782 | 26,676 | 26,312 | 27,788 | 28,276 | 30,656 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Short Term Borrowings | 0 | 0 | 1 | 4 | 6 | 11 | 2,126 | - | - | - | 0 | 514 | |||||
Long Term Debt And Capital Lease Obligations Curre… | 844 | 842 | 2 | 751 | 2 | 651 | 626 | 2,498 | 2,468 | 2,634 | 2,667 | 1,912 | |||||
Accounts Payable Current | 1,034 | 1,086 | 999 | 953 | 995 | 963 | 968 | 841 | 1,251 | 1,329 | 881 | 1,246 | |||||
Accrued Liabilities Current | 1,713 | 1,765 | 1,968 | 2,067 | 1,936 | 1,856 | 1,861 | 1,772 | 2,412 | 2,402 | 1,915 | 2,537 | |||||
Liabilities Of Disposal Group Including Discontinu… | - | - | 0 | 0 | 0 | 0 | 930 | 1,089 | - | - | 1,040 | 0 | |||||
Liabilities Current | 3,591 | 3,693 | 2,970 | 3,775 | 2,939 | 3,481 | 6,511 | 6,200 | 6,131 | 6,365 | 6,503 | 6,209 | |||||
Long Term Debt And Capital Lease Obligations | - | - | 9,473 | - | - | - | 10,374 | 10,437 | 10,436 | 11,092 | 11,089 | 14,067 | |||||
Operating Lease Liability Noncurrent | 208 | 224 | 223 | 210 | 225 | 235 | 243 | 259 | 439 | 444 | 265 | 436 | |||||
Other Liabilities Noncurrent | 1,198 | 1,292 | 1,287 | 1,121 | 1,097 | 1,122 | 1,076 | 1,263 | 1,598 | 1,652 | 1,400 | 1,778 | |||||
Liabilities Of Disposal Group Including Discontinu… | - | - | 0 | 0 | 0 | 0 | 554 | 575 | - | - | 551 | 0 | |||||
Liabilities | 13,612 | 13,830 | 13,953 | 13,853 | 13,753 | 14,250 | 18,758 | 18,734 | 18,604 | 19,553 | 19,808 | 22,490 | |||||
Common Stock Value | 683 | 683 | 683 | 683 | 683 | 683 | 683 | 683 | 683 | 683 | 683 | 683 | |||||
Treasury Stock Common Value | -10,705 | -10,737 | -10,873 | -10,891 | -10,915 | -10,937 | -11,059 | -11,084 | -11,104 | -11,130 | -11,230 | -11,249 | |||||
Additional Paid In Capital Common Stock | 6,241 | 6,214 | 6,368 | 6,345 | 6,328 | 6,309 | 6,421 | 6,391 | 6,353 | 6,339 | 6,389 | 6,368 | |||||
Retained Earnings Accumulated Deficit | 13,806 | 13,685 | 13,705 | 14,837 | 14,970 | 14,968 | 14,929 | 15,529 | 15,539 | 16,003 | 16,114 | 16,015 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -3,819 | -3,802 | -3,754 | -3,733 | -3,746 | -3,942 | -4,010 | -3,647 | -3,828 | -3,722 | -3,554 | -3,716 | |||||
Stockholders Equity | 6,179 | 6,016 | 6,102 | 7,214 | 7,293 | 7,081 | 6,964 | 7,872 | 7,708 | 8,235 | 8,468 | 8,166 | |||||
Minority Interest | -27 | -27 | -27 | -27 | -27 | -27 | 60 | 70 | 65 | 62 | 66 | 65 | |||||
Liabilities And Stockholders Equity | 19,791 | 19,846 | 20,055 | 21,067 | 21,046 | 21,304 | 25,782 | 26,676 | 26,312 | 27,788 | 28,276 | 30,656 | |||||
Allowance For Doubtful Accounts Receivable Current | 56 | 67 | 63 | 69 | 71 | 66 | 71 | 65 | 123 | 121 | 62 | 132 | |||||
Common Stock Par Or Stated Value Per Share | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Common Stock Shares Authorized | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | |||||
Common Stock Shares Issued | 683 | 683 | 683 | 683 | 683 | 683 | 683 | 683 | 683 | 683 | 683 | 683 | |||||
Treasury Stock Common Shares | 166 | 167 | 169 | 170 | 170 | 170 | 173 | 173 | 173 | 174 | 176 | 176 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 9.10% | 13.20% | 28.68% | - | - | - | - | - | - | - | - | - |
| 2025 | 2.47% | 2.10% | -1.83% | 8.86% | -3.09% | 1.50% | 4.51% | 8.08% | 10.65% | -5.41% | -10.81% | -7.97% |
| 2024 | -8.15% | -6.29% | -3.39% | 3.55% | 6.20% | -1.83% | -5.52% | -12.35% | -3.26% | 2.77% | -17.28% | -8.19% |
| 2023 | - | - | - | - | - | - | 5.17% | 12.96% | 13.61% | 2.07% | 6.38% | -0.12% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 1.95 | 1.85 | 2.31 | 1.84 | 2.30 | 2.02 | 1.36 | 1.43 | 1.40 | 1.48 | 1.48 | 1.94 | |||||
| Quick Ratio | 1.12 | 1.01 | 1.29 | 0.93 | 1.18 | 1.13 | 0.93 | 0.97 | 0.77 | 0.87 | 1.07 | 1.34 | |||||
| Working Capital | 3.40B | 3.15B | 3.90B | 3.16B | 3.81B | 3.55B | 2.34B | 2.66B | 2.46B | 3.04B | 3.10B | 5.83B | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 2.20 | 2.30 | 2.29 | 1.92 | 1.89 | 2.01 | 2.67 | 2.38 | 2.41 | 2.37 | 2.34 | 2.75 | |||||
| Interest Coverage TTM | -1.11 | -1.25 | -1.29 | -0.05 | -0.10 | -0.13 | 0.04 | 1.97 | 1.86 | 1.34 | 1.27 | 1.03 | |||||
| Debt Ratio | 0.69 | 0.70 | 0.70 | 0.66 | 0.65 | 0.67 | 0.73 | 0.70 | 0.71 | 0.70 | 0.70 | 0.73 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.56 | 0.55 | 0.49 | 0.46 | 0.46 | 0.44 | 0.39 | 0.29 | 0.31 | 0.33 | 0.37 | 0.46 | |||||
| Days Sales Outstanding TTM | 57.74 | 53.91 | 57.46 | 58.05 | 73.96 | 70.60 | 58.31 | 91.88 | 112.56 | 99.06 | 75.57 | 68.93 | |||||
| Receivables Turnover TTM | 6.32 | 6.77 | 6.35 | 6.29 | 4.94 | 5.17 | 6.26 | 3.97 | 3.24 | 3.68 | 4.83 | 5.30 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -2.05 | -2.13 | -1.87 | -0.65 | -0.29 | -1.07 | -1.25 | 0.22 | 4.86 | 5.21 | 5.24 | 5.12 | |||||
| Free Cash Flow Per Share TTM | 2.55 | 2.41 | 1.63 | 1.44 | 1.46 | 1.28 | 1.97 | 1.92 | 1.81 | 1.98 | 2.28 | 1.87 | |||||
| Dividend Per Share TTM | 0.36 | 0.52 | 0.68 | 0.79 | 0.91 | 1.04 | 1.16 | 1.16 | 1.15 | 1.16 | 1.16 | 1.15 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 30.08% | 30.11% | 30.05% | 34.12% | 35.31% | 36.06% | 37.46% | 44.31% | 45.12% | 41.08% | 40.06% | 35.36% | |||||
| Operating Profit Margin TTM | -2.39% | -2.65% | -2.74% | -0.13% | -0.28% | -0.40% | 0.13% | 10.27% | 10.68% | 7.42% | 6.82% | 3.73% | |||||
| Net Profit Margin TTM | -9.27% | -9.70% | -8.51% | -3.02% | -1.35% | -5.10% | -6.00% | 1.34% | 29.84% | 28.45% | 25.70% | 19.41% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 5.36% | 5.10% | 5.72% | 30.85% | 30.79% | 15.36% | 2.66% | -37.20% | -42.29% | -34.76% | -28.58% | -7.00% | |||||
| Net Income Growth (1Y) | 623.13% | 100.00% | 50.00% | -394.69% | -105.92% | -120.67% | -123.96% | -95.66% | -187.43% | -208.41% | -210.00% | -210.25% | |||||
| EPS Growth (1Y) | 617.53% | 98.83% | 49.12% | -392.40% | -105.88% | -120.51% | -123.77% | -95.69% | -186.75% | -207.77% | -209.56% | -209.59% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -10.37 | -7.88 | -10.23 | -35.09 | -104.77 | -31.48 | -22.87 | 167.30 | 6.65 | 7.85 | 7.01 | 6.95 | |||||
| P/B TTM | 1.78 | 1.44 | 1.60 | 1.62 | 2.11 | 2.44 | 2.08 | 2.40 | 2.14 | 2.53 | 2.20 | 2.22 | |||||
| P/S TTM | 0.96 | 0.76 | 0.87 | 1.06 | 1.41 | 1.60 | 1.37 | 2.24 | 1.99 | 2.23 | 1.80 | 1.35 | |||||
| Market Cap | 11.02B | 8.65B | 9.79B | 11.69B | 15.40B | 17.28B | 14.59B | 18.90B | 16.53B | 20.85B | 18.66B | 18.10B | |||||
| Enterprise Value | 9.72B | 7.47B | 17.30B | 10.71B | 13.72B | 15.65B | 25.95B | 30.42B | 27.86B | 31.75B | 29.33B | 28.88B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 1.32B | 1.24B | 836.00M | 740.00M | 751.00M | 656.00M | 1.01B | 979.00M | 922.00M | 1.00B | 1.15B | 950.00M | |||||
| Net Debt | -1.31B | -1.18B | 7.51B | -971.00M | -1.68B | -1.63B | 11.36B | 11.52B | 11.33B | 10.90B | 10.67B | 10.78B | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
BAXTER INTERNATIONAL INC (BAX) — SEC Financial Statements & Analysis
BAXTER INTERNATIONAL INC (BAX) is a surgical & medical instruments & apparatus company, incorporated in DE. BAXTER INTERNATIONAL INC trades on NYSE as: BAX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), BAXTER INTERNATIONAL INC reported a 5.36% year-over-year revenue growth, a Gross Profit Margin of 30.08% (TTM), a Debt-to-Equity ratio of 2.20x, a Price-to-Sales (P/S) ratio of 0.96x (TTM), a Price-to-Book (P/B) ratio of 1.78x (TTM), at a market cap of $11.02B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 5.36%
- Gross Profit Margin TTM
- 30.08%
- Debt To Equity
- 2.20x
- P/S TTM
- 0.96x
- P/B TTM
- 1.78x
- Market Cap
- $11.02B
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is BAXTER INTERNATIONAL INC in?
BAXTER INTERNATIONAL INC (BAX) operates in the Surgical & Medical Instruments & Apparatus industry.
What is BAX's market cap?
BAXTER INTERNATIONAL INC (BAX) has a market capitalization of $11.02B as of 2026-06-30.
What exchange does BAX trade on?
BAXTER INTERNATIONAL INC (BAX) trades on the NYSE.
Where is BAXTER INTERNATIONAL INC incorporated?
BAXTER INTERNATIONAL INC is incorporated in DE.